HighMark Wealth Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-82
| Closed | -$2.52K | – | 580 |
|
|
2023
Q2 | $2.52K | Buy |
82
+21
| +34% | +$646 | ﹤0.01% | 436 |
|
|
2023
Q1 | $2.2K | Buy |
+61
| New | +$2.2K | ﹤0.01% | 491 |
|
|
2022
Q4 | – | Sell |
-64
| Closed | -$3K | – | 560 |
|
|
2022
Q3 | $3K | Hold |
64
| – | – | ﹤0.01% | 400 |
|
|
2022
Q2 | $3K | Hold |
64
| – | – | ﹤0.01% | 406 |
|
|
2022
Q1 | $2K | Hold |
64
| – | – | ﹤0.01% | 453 |
|
|
2021
Q4 | $3K | Hold |
64
| – | – | ﹤0.01% | 414 |
|
|
2021
Q3 | $2K | Sell |
64
-8
| -11% | -$250 | ﹤0.01% | 461 |
|
|
2021
Q2 | $3K | Sell |
72
-18
| -20% | -$750 | ﹤0.01% | 428 |
|
|
2021
Q1 | $4K | Buy |
90
+23
| +34% | +$1.02K | ﹤0.01% | 370 |
|
|
2020
Q4 | $3K | Buy |
67
+7
| +12% | +$313 | ﹤0.01% | 391 |
|
|
2020
Q3 | $3K | Buy |
+60
| New | +$3K | ﹤0.01% | 376 |
|